top of page

Population Health and Cancer Control

Dr. Angie Brooks-Wilson

Dr. Brooks-Wilson leads a cancer genetics research laboratory at the Genome Sciences Centre of the British Columbia Cancer Agency here in Vancouver, BC.  Her current work focuses on the genetics of healthy aging and the genetics of susceptibility to cancer, particularly lymphoid cancers, in families and populations. She leads the Healthy Aging Study in which exceptionally healthy elderly individuals (‘Super-Seniors’) are helping to determine the genetic influences that contribute to healthy aging and protect against age-related diseases.

Admin Email:

Dr. Kristin Campbell

Kristin Campbell, BSc, PT, PhD is a licensed physical therapist and Professor in the Department of Physical Therapy at the University of British Columbia. She also holds an appointment in Cancer Control at the BC Cancer Research Institute. She completed her PhD in exercise physiology at the University of Alberta and a Fellowship in Public Health at the Fred Hutchinson Cancer Research Centre. Her research focus is on the role of exercise and energy balance in cancer prevention, rehabilitation and survivorship. Dr. Campbell is the author of over 165 peer reviewed articles and academic book chapters and she participates on national and international advisory boards and grant review panels on cancer prevention, rehabiliation and survivorship. In 2020, she received a Distinguished Achievement Award for Overall Excellence Mid-Career from the Faculty of Medicine at UBC and a Visiting Scholar Award from the American College of Sports Medicine in 2022.

Dr. Martin Gleave

Dr. Gleave is a clinician-scientist and urologic surgeon whose clinical practice focuses on urologic oncology in a multi-disciplinary environment at the leading edge of assessing new technologies and treatments across both localized and advanced cancers. His research characterizes molecular mechanisms mediating treatment resistance in cancer, focusing on adaptive survival responses that drive acquired treatment resistance, and designing combination co-targeting strategies to create conditional lethality and improve cancer control. He patented several anti-cancer drugs and in 2001 founded OncoGenex Pharmaceuticals to develop OGX-011 and OGX-427, inhibitors of cytoprotective chaperones clusterin and Hsp27 now in Phase III and Phase II trials world-wide. He has co-founded several other companies including Sitka Pharma, TRiADD, and Sustained Therapeutics.

Dr. Kristen Haase

My research program centres on understanding the experiences of older adults as they manage cancer, chronic disease, and wellbeing. I have two main interests: (1) supporting older adults with cancer and their carers and (2) leveraging technology to support people with cancer and other chronic diseases. The goal of my program of research is to engage older adults with lived experience of cancer and chronic disease to co-lead the development of community-based interventions to improve quality of life and wellbeing amongst older adults and their caregivers.

Dr. Stephen Lam

Stephen Lam MD, FRCPC is Professor of Medicine at the University of British Columbia and a Distinguished Scientist, the Leon Judah Blackmore Chair in lung cancer research and MDS-Rix endowed director of translation lung cancer research at the BC Cancer Research Center. He chairs the BC Cancer Agency Provincial Lung Tumor Group. His research interest is in screening, chemoprevention and endoscopic diagnosis of early lung cancer. He has published over 280 peer reviewed papers and book chapters. He was the recipient of the IASLC Joseph Cullen Award for life-time scientific achievements in lung cancer prevention research, the Friesen Rygiel Award for Outstanding Canadian Academic Discovery, the Gustav Killian Medal by the World Association of Bronchology for pioneering contributions to the field early lung cancer diagnosis, as well as the Killam Research Prize in Applied Sciences and the Distinguished Achievement Award from the University of British Columbia. Dr. Lam received his medical training at the University of Toronto. He joined the UBC Faculty of Medicine in 1979 and the BC Cancer Agency in 1984.

Dr. Jonathan Loree

Jonathan Loree is a medical oncologist at BC Cancer with an interest in GI malignancies. He completed his medical oncology fellowship at BC Cancer and subsequently undertook a translational research fellowship at MD Anderson Cancer Center where he completed a Master’s of Science before returning to British Columbia. His research focus is translational research and biomarker development in colorectal cancer and neuroendocrine neoplasms and he serves as the co-chair of the colon cancer disease site for the Canadian Cancer Trials Group.

Dr. Rachel Murphy

Dr. Rachel Murphy, is an Scientist at the BC Cancer, and Assistant Professor in the Centre of Excellence in Cancer Prevention, School of Population and Public Health, University of British Columbia. She is also an Associate Member in the Human Nutrition Program at the Faculty of Land and Food Systems. Dr. Murphy holds a PhD in Nutrition and Metabolism from the University of Alberta. Her research program aims to advance the understanding of relationships between diet, nutrition and chronic disease, particularly cancer. Her research primarily uses a population-based approach and innovative methodologies to study metabolic pathways underlying relationships. She received one of two Awards from the Canadian Cancer Society Research Institute Career Development Awards in 2016, which supports researchers whose work has the potential for high impact.

Dr. Robert Olsen

Clinical Research and Nursing, Population Health and Cancer Control

Dr. Olson is a clinician scientist. He is practicing Radiation Oncologist at the BC Cancer Agency Centre for the North, in Prince George, treating breast, head & neck, and lung cancers, with an interest in stereotactic ablative radiotherapy for oligometastatic disease. His research is focused on Health Services Delivery, including prescribing practices of oncologists, and integrating patient reported outcomes into routine clinical care in order to guide care, quality improvement, and research.

Dr. Stuart Peacock

Population Health and Cancer Control

Stuart Peacock holds the Leslie Diamond Chair in Cancer Survivorship in the Faculty of Health Sciences at Simon Fraser University. He is Co-Director of the Canadian Centre for Applied Research in Cancer Control (ARCC) and Head of Cancer Control Research at the British Columbia Cancer Agency. Over the past 20 years, Stuart’s main interests have focussed on research into developing more effective cancer systems, making health system funding decisions fairer and more transparent, and improving the quality of life of cancer patients and survivors. 

bottom of page